Cargando…
Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing
Background: Chordoma is a rare primary malignant bone tumour. Treatment options are mainly restricted to surgical excision, since chordomas are largely resistant to conventional ionising radiation and chemotherapy. Thus, there is a strong need to gain more thorough insights into the molecular biolog...
Autores principales: | Fischer, Carina, Scheipl, Susanne, Zopf, Agnes, Niklas, Norbert, Deutsch, Alexander, Jorgensen, Mette, Lohberger, Birgit, Froehlich, Elke Verena, Leithner, Andreas, Gabriel, Christian, Liegl-Atzwanger, Bernadette, Rinner, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565847/ https://www.ncbi.nlm.nih.gov/pubmed/26366211 http://dx.doi.org/10.7150/jca.11371 |
Ejemplares similares
-
Chordoma Characterization of Significant Changes of the DNA Methylation Pattern
por: Rinner, Beate, et al.
Publicado: (2013) -
Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma
por: Lohberger, Birgit, et al.
Publicado: (2021) -
Drug combination screening as a translational approach toward an improved drug therapy for chordoma
por: Scheipl, Susanne, et al.
Publicado: (2021) -
Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies
por: Gellner, Verena, et al.
Publicado: (2016) -
The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
por: Lohberger, Birgit, et al.
Publicado: (2013)